FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074301268> ?p ?o ?g. }

• W2074301268 endingPage "338" @default.
• W2074301268 startingPage "333" @default.
• W2074301268 abstract "Variceal bleeding is one of the major complications of portal hypertension. Gastric variceal (GV) bleeding is less common than esophageal variceal (EV) bleeding, however, is associated with a high morbidity and mortality. Balloon-occluded retrograde transvenous obliteration (BRTO) is an established procedure for the management of gastric varices in Japan and has shown promising results in the past decade. The technical success rate, intent-to-treat (including technically failed BRTO-procedures) obliteration rate, and the obliteration rate of gastric varices of technically successful BRTO procedures was 91% (79-100%), 86% (73-100%), and 94% (75-100), respectively. BRTO is successful in controlling active gastric variceal bleeding in 95% of cases (91-100%) and in significantly reducing or resolving encephalopathy in 100% of cases. However, BRTO diverts blood into the portal circulation and increases the portal hypertension, thus aggravating esophageal varices with their potential for bleeding. The 1-, 2-, and 3-year esophageal variceal aggravation rates are 27-35%, 45-66%, and 45-91%, respectively. The gastric variceal rebleed rate of successful BRTO procedures, the intent-to-treat gastric variceal rebleed rate, and the global (all types of varices) variceal rebleed rate are 3.2-8.7%, 10-20%, and 19-31%, respectively. However, the advantage of diverting blood into the portal circulation and potentially toward the liver is improved hepatic function and possible patient survival. Unfortunately, the improved hepatic function is transient (for 6-12 months); however, it is preserved in the long-term (1-3 years). Patient 1-, 2-, 3-, and 5-year survival rates are 83-98%, 76-79%, 66-85%, and 39-69%, respectively. Patient survival is determined by baseline hepatic reserve and the presence of hepatocellular carcinoma." @default.
• W2074301268 created "2016-06-24" @default.
• W2074301268 creator A5013122511 @default.
• W2074301268 creator A5021487581 @default.
• W2074301268 date "2011-08-15" @default.
• W2074301268 modified "2023-10-16" @default.
• W2074301268 title "Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technical Results and Outcomes" @default.
• W2074301268 cites W1483130183 @default.
• W2074301268 cites W1494564168 @default.
• W2074301268 cites W1758140484 @default.
• W2074301268 cites W1968656382 @default.
• W2074301268 cites W1978031730 @default.
• W2074301268 cites W1981321482 @default.
• W2074301268 cites W1989240964 @default.
• W2074301268 cites W2004534190 @default.
• W2074301268 cites W2008100675 @default.
• W2074301268 cites W2020658070 @default.
• W2074301268 cites W2020946485 @default.
• W2074301268 cites W2021105374 @default.
• W2074301268 cites W2035291334 @default.
• W2074301268 cites W2037330000 @default.
• W2074301268 cites W2040757873 @default.
• W2074301268 cites W2045431308 @default.
• W2074301268 cites W2049614321 @default.
• W2074301268 cites W2053891224 @default.
• W2074301268 cites W2057657489 @default.
• W2074301268 cites W2059251186 @default.
• W2074301268 cites W2067787808 @default.
• W2074301268 cites W2071595573 @default.
• W2074301268 cites W2079874872 @default.
• W2074301268 cites W2088408005 @default.
• W2074301268 cites W2091288557 @default.
• W2074301268 cites W2092267776 @default.
• W2074301268 cites W2098604060 @default.
• W2074301268 cites W2101665195 @default.
• W2074301268 cites W2105569474 @default.
• W2074301268 cites W2122011331 @default.
• W2074301268 cites W2125872386 @default.
• W2074301268 cites W2137301015 @default.
• W2074301268 cites W2138435662 @default.
• W2074301268 cites W2150012480 @default.
• W2074301268 cites W2151188296 @default.
• W2074301268 cites W2153939200 @default.
• W2074301268 cites W2160710840 @default.
• W2074301268 cites W2398226089 @default.
• W2074301268 cites W2399853678 @default.
• W2074301268 cites W2403581901 @default.
• W2074301268 cites W2409140051 @default.
• W2074301268 cites W2416685767 @default.
• W2074301268 cites W244853167 @default.
• W2074301268 cites W2467583754 @default.
• W2074301268 cites W2807603863 @default.
• W2074301268 cites W2115638558 @default.
• W2074301268 doi "https://doi.org/10.1055/s-0031-1284460" @default.
• W2074301268 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3312162" @default.
• W2074301268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22942551" @default.
• W2074301268 hasPublicationYear "2011" @default.
• W2074301268 type Work @default.
• W2074301268 sameAs 2074301268 @default.
• W2074301268 citedByCount "80" @default.
• W2074301268 countsByYear W20743012682012 @default.
• W2074301268 countsByYear W20743012682013 @default.
• W2074301268 countsByYear W20743012682014 @default.
• W2074301268 countsByYear W20743012682015 @default.
• W2074301268 countsByYear W20743012682016 @default.
• W2074301268 countsByYear W20743012682017 @default.
• W2074301268 countsByYear W20743012682018 @default.
• W2074301268 countsByYear W20743012682019 @default.
• W2074301268 countsByYear W20743012682020 @default.
• W2074301268 countsByYear W20743012682021 @default.
• W2074301268 countsByYear W20743012682022 @default.
• W2074301268 countsByYear W20743012682023 @default.
• W2074301268 crossrefType "journal-article" @default.
• W2074301268 hasAuthorship W2074301268A5013122511 @default.
• W2074301268 hasAuthorship W2074301268A5021487581 @default.
• W2074301268 hasBestOaLocation W20743012682 @default.
• W2074301268 hasConcept C126322002 @default.
• W2074301268 hasConcept C126838900 @default.
• W2074301268 hasConcept C139059822 @default.
• W2074301268 hasConcept C141071460 @default.
• W2074301268 hasConcept C2777214474 @default.
• W2074301268 hasConcept C2777595160 @default.
• W2074301268 hasConcept C2778012290 @default.
• W2074301268 hasConcept C2778808290 @default.
• W2074301268 hasConcept C2779195621 @default.
• W2074301268 hasConcept C2780325230 @default.
• W2074301268 hasConcept C56900294 @default.
• W2074301268 hasConcept C71924100 @default.
• W2074301268 hasConceptScore W2074301268C126322002 @default.
• W2074301268 hasConceptScore W2074301268C126838900 @default.
• W2074301268 hasConceptScore W2074301268C139059822 @default.
• W2074301268 hasConceptScore W2074301268C141071460 @default.
• W2074301268 hasConceptScore W2074301268C2777214474 @default.
• W2074301268 hasConceptScore W2074301268C2777595160 @default.
• W2074301268 hasConceptScore W2074301268C2778012290 @default.
• W2074301268 hasConceptScore W2074301268C2778808290 @default.
• W2074301268 hasConceptScore W2074301268C2779195621 @default.
• W2074301268 hasConceptScore W2074301268C2780325230 @default.

• next